Chapter 1 Executive Summary
- Market Outlook
- Scope of Report
- Market Summary
Chapter 2 Market Overview
- Market Overview and Definitions
- Immunohistochemistry (IHC)
- In Situ Hybridization
- Polymerase Chain Reaction
- Next-Generation Sequencing
- General Culture Testing
Chapter 3 Market Dynamics
- Market Dynamics
- Market Drivers
- Increasing Incidence of Cancer Cases
- Companion Diagnostics in Cancer Treatment
- Importance of Early Cancer Testing
- Raising Awareness of Early Signs of Cancer
- Aging Population
- Market Opportunities
- Enhancing Access
- Digital Pathology
- Partnerships
- Market Restraints
- Cost of Tissue Diagnostic Tests
- Competing Technologies
- Turnaround Time
- Market Challenges
- Lack of Skilled Professionals
- Complex Sample Preparation and Handling
Chapter 4 Emerging Technologies and Developments
- Overview
- Digital Pathology and AI Integration
- 3D Tissue Pathology and AI
- Fluorescent In Situ Sequencing
Chapter 5 Tissue Diagnostics Testing Market
- Segmentation Breakdown
- Market Breakdown
- Market Breakdown, by Product Type
- Market Breakdown, by Technology
- Market Breakdown, by Segment
- Histopathology Market
- Molecular Pathology Market
- Microbiology Testing Market
- Digital Pathology Market
- Market Breakdown, by Application
- Market Breakdown, by End User
- Geographic Breakdown
- Market Breakdown, by Region
- North America
- Europe
- Asia-Pacific
- Latin America
- Rest of the World
Chapter 6 Competitive Intelligence
- Industry Scenario
- Competitive Landscape
Chapter 7 Sustainability in the Market for Tissue Diagnostics: An ESG Perspective
- Introduction to ESG
- Environmental Performance
- Social Performance
- Governance Performance
- Concluding Remarks
List of Tables
Summary Table: Global Tissue Diagnostics Market, by Product Type, Through 2029
Table 1: Global Incidence of All Cancers, by Region, 2022-2045
Table 2: Cancer Cases, by Country, 2022
Table 3: Incidence of Cancer, by Cancer Type, 2022
Table 4: Cancer Treatments Based on Specific Tests
Table 5: Global Tissue Diagnostics Market, Through 2029
Table 6: Global Tissue Diagnostics Market, by Product Type, Through 2029
Table 7: Global Tissue Diagnostics Market, by Technology, Through 2029
Table 8: Global IHC Tissue Diagnostics Market, by Region, Through 2029
Table 9: Global H&E and Special Stains Diagnostics Market, by Region, Through 2029
Table 10: Global ISH Tissue Diagnostics Market, by Region, Through 2029
Table 11: Global PCR Tissue Diagnostics Market, by Region, Through 2029
Table 12: Global NGS Tissue Diagnostics Market, by Region, Through 2029
Table 13: Global Digital Pathology Market, by Region, Through 2029
Table 14: Global Tissue Diagnostics Market, by Segment Type, Through 2029
Table 15: Global Histopathology Market, by Product Type, Through 2029
Table 16: Global Histopathology Market, by Region, Through 2029
Table 17: Global Molecular Pathology Market, by Product Type, Through 2029
Table 18: Global Molecular Pathology Market, by Region, Through 2029
Table 19: Global Microbiology Testing Market, by Product Type, Through 2029
Table 20: Global Microbiology Testing Market, by Region, Through 2029
Table 21: Global Digital Pathology Market, Through 2029
Table 22: Global Digital Pathology Market, by Region, Through 2029
Table 23: Global Tissue Diagnostics Market, by Application, Through 2029
Table 24: Global Tissue Diagnostics Market, by End User, Through 2029
Table 25: Global Tissue Diagnostics Market, by Region, Through 2029
Table 26: North American Tissue Diagnostics Market, by Country, Through 2029
Table 27: European Tissue Diagnostics Market, by Country, Through 2029
Table 28: Asia-Pacific Tissue Diagnostics Market, by Country, Through 2029
Table 29: Latin American Tissue Diagnostics Market, by Country, Through 2029
Table 30: RoW Tissue Diagnostics Market, Through 2029
Table 31: ESG: Environmental Overview
Table 32: ESG: Social Overview
Table 33: ESG: Governance Overview
Table 34: Acronyms Used in this Report
Table 35: Abbott: Company Snapshot
Table 36: Abbott: Financial Performance, FY 2022 and 2023
Table 37: Abbott: Product Portfolio
Table 38: Agilent Technologies Inc.: Company Snapshot
Table 39: Agilent Technologies Inc.: Financial Performance, FY 2022 and 2023
Table 40: Agilent Technologies Inc.: Product Portfolio
Table 41: Agilent Technologies Inc.: News/Key Developments, 2024
Table 42: BD: Company Snapshot
Table 43: BD: Financial Performance, FY 2022 and 2023
Table 44: BD: Product Portfolio
Table 45: Biocare Medical LLC.: Company Snapshot
Table 46: Biocare Medical LLC.: Product Portfolio
Table 47: Biomerieux: Company Snapshot
Table 48: Biomerieux: Financial Performance, FY 2022 and 2023
Table 49: Biomerieux: Product Portfolio
Table 50: Bio-Rad Laboratories Inc.: Company Snapshot
Table 51: Bio-Rad Laboratories Inc.: Financial Performance, FY 2022 and 2023
Table 52: Bio-Rad Laboratories Inc.: Product Portfolio
Table 53: Danaher Corp.: Company Snapshot
Table 54: Danaher Corp.: Financial Performance, FY 2022 and 2023
Table 55: Danaher Corp.: Product Portfolio
Table 56: Danaher Corp.: News/Key Developments, 2023
Table 57: F. Hoffmann-La Roche Ltd.: Company Snapshot
Table 58: F. Hoffmann-La Roche Ltd.: Financials, FY 2022 and 2023
Table 59: F. Hoffmann-La Roche Ltd.: Product Portfolio
Table 60: F. Hoffmann-La Roche Ltd.: News/Key Developments, 2024
Table 61: Illumina Inc.: Company Snapshot
Table 62: Illumina Inc.: Financial Performance, FY 2022 and 2023
Table 63: Illumina Inc.: Product Portfolio
Table 64: Illumina Inc.: News/Key Developments, 2024
Table 65: Koninklijke Philips N.V.: Company Snapshot
Table 66: Koninklijke Philips N.V.: Financial Performance, FY 2022 and 2023
Table 67: Koninklijke Philips N.V.: Product Portfolio
Table 68: Merck KGaA: Company Snapshot
Table 69: Merck KGaA: Financial Performance, FY 2022 and 2023
Table 70: Merck KGaA: Product Portfolio
Table 71: Myriad Genetics Inc.: Company Snapshot
Table 72: Myriad Genetics Inc.: Financial Performance, FY 2022 and 2023
Table 73: Myriad Genetics Inc.: Product Portfolio
Table 74: QIAGEN.: Company Snapshot
Table 75: QIAGEN.: Financial Performance, FY 2022 and 2023
Table 76: QIAGEN.: Product Portfolio
Table 77: Thermo Fisher Scientific Inc.: Company Snapshot
Table 78: Thermo Fisher Scientific Inc.: Financial Performance, FY 2022 and 2023
Table 79: Thermo Fisher Scientific Inc.: Product Portfolio
Table 80: ZytoVision GmbH: Company Snapshot
Table 81: ZytoVision GmbH: Product Portfolio
List of Figures
Summary Figure A: Global Tissue Diagnostics Market, by Product Type, 2021-2029
Summary Figure B: Shares of Global Market for Tissue Diagnostics, by Product Type, 2023
Figure 1: Market Dynamics of Tissue Diagnostics
Figure 2: Shares of All Cancer Cases, by Region, 2022
Figure 3: Emerging Trends and Technologies in Tissue Diagnostics
Figure 4: Shares of Global Market for Tissue Diagnostics, by Technology, 2023
Figure 5: Shares of Global Market for Tissue Diagnostics, by Segment Type, 2023
Figure 6: Shares of Global Market for Histopathology, by Product Type, 2023
Figure 7: Shares of Global Market for Molecular Pathology, by Product Type, 2023
Figure 8: Shares of Global Market for Microbiology Testing, by Product Type, 2023
Figure 9: Shares of Global Market for Tissue Diagnostics, by Application, 2023
Figure 10: Shares of Global Market for Tissue Diagnostics, by End User, 2023
Figure 11: Shares of Global Market for Tissue Diagnostics, by Region, 2023
Figure 12: Shares of North American Market for Tissue Diagnostics, by Country, 2023
Figure 13: Shares of European Market for Tissue Diagnostics, by Country, 2023
Figure 14: Shares of Asia-Pacific Market for Tissue Diagnostics, by Country, 2023
Figure 15: Shares of Latin American Tissue Diagnostics Market, by Country, 2023
Figure 16: Shares of Global Market for Tissue Diagnostics, by Company, 2023
Figure 17: ESG Pillars
Figure 18: Advantages of ESG for Companies
Figure 19: Abbott: Revenue Shares, by Business Unit, FY 2023
Figure 20: Abbott: Revenue Shares, by Country/Region, FY 2023
Figure 21: Agilent Technologies Inc.: Revenue Shares, by Business Unit, FY 2023
Figure 22: Agilent Technologies Inc.: Revenue Shares, by Country/Region, FY 2023
Figure 23: BD: Revenue Shares, by Business Unit, FY 2023
Figure 24: BD: Revenue Shares, by Country/Region, FY 2023
Figure 25: Biomerieux: Revenue Shares, by Business Unit, FY 2023
Figure 26: Biomerieux: Revenue Shares, by Country/Region, FY 2023
Figure 27: Bio-Rad Laboratories Inc.: Revenue Shares, by Business Unit, FY 2023
Figure 28: Bio-Rad Laboratories Inc.: Revenue Shares, by Country/Region, FY 2023
Figure 29: Danaher Corp.: Revenue Shares, by Business Unit, FY 2023
Figure 30: Danaher Corp.: Revenue Shares, by Country/Region, FY 2023
Figure 31: F. Hoffmann-La Roche Ltd.: Revenue Shares, by Business Unit, FY 2023
Figure 32: F. Hoffmann-La Roche Ltd.: Revenue Shares, by Country/Region, FY 2023
Figure 33: Illumina Inc.: Revenue Shares, by Business Unit, FY 2023
Figure 34: Illumina Inc.: Revenue Shares, by Country/Region, FY 2023
Figure 35: Koninklijke Philips N.V.: Revenue Shares, by Business Unit, FY 2023
Figure 36: Koninklijke Philips N.V.: Revenue Shares, by Country/Region, FY 2023
Figure 37: Merck KGaA: Market Shares, by Business Unit, FY 2023
Figure 38: Merck KGaA: Revenue Shares, by Country/Region, FY 2023
Figure 39: Myriad Genetics Inc.: Revenue Shares, by Business Unit, FY 2023
Figure 40: Myriad Genetics Inc.: Revenue Shares, by Country/Region, FY 2023
Figure 41: QIAGEN.: Revenue Shares, by Business Unit, FY 2023
Figure 42: QIAGEN.: Revenue Shares, by Country/Region, FY 2023
Figure 43: Thermo Fisher Scientific Inc.: Revenue Shares, by Business Unit, FY 2023
Figure 44: Thermo Fisher Scientific Inc.: Revenue Shares, by Country/Region, FY 2023